3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
14
Lymphoma, Large B-Cell, Diffuse
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Follicular
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, B-Cell
4
Wilms Tumor
3
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Plasmablastic Lymphoma
2
Neoplasms
2
Medulloblastoma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Leukemia
2
Ganglioneuroblastoma
2
Down Syndrome
2
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroblastoma
1
Multi-centric Castleman's Disease
1
Malignant mesenchymal tumor
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Vincristine
×
30 days
×
Clear all
No trials found.